Calamos Advisors LLC Rx Sight, Inc. Transaction History
Calamos Advisors LLC
- $16.1 Billion
- Q3 2024
A detailed history of Calamos Advisors LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 53,932 shares of RXST stock, worth $1.87 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
53,932
Previous 75,041
28.13%
Holding current value
$1.87 Million
Previous $4.52 Million
40.97%
% of portfolio
0.02%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding RXST
# of Institutions
224Shares Held
32.3MCall Options Held
394KPut Options Held
32K-
Ra Capital Management, L.P. Boston, MA3.92MShares$135 Million2.7% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.29MShares$79.1 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.75MShares$60.4 Million0.01% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.17MShares$40.5 Million0.09% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $956M
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...